Ignite Creation Date:
2025-12-25 @ 2:36 AM
Ignite Modification Date:
2025-12-27 @ 11:49 PM
Study NCT ID:
NCT04789434
Status:
UNKNOWN
Last Update Posted:
2021-11-22
First Post:
2021-03-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT
Sponsor:
Ruijin Hospital
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-07-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-07-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-07-01
Completion Date Type:
ESTIMATED
First Submit Date:
2021-03-06
First Submit QC Date:
None
Study First Post Date:
2021-03-09
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-14
Last Update Post Date:
2021-11-22
Last Update Post Date Type:
ACTUAL